RecruitingNCT04344912
Impact of COVID19 Outbreak in Cardiac Acute Care
Impact of COVID19 Outbreak in Cardiac Patients Admitted in Intensive Care Unit : the CCU-COVID19 Study
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
500 participants
Start Date
Mar 20, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This registry will evaluate the impact of the COVID19 outbreak on Cardiac patients admitted in the Intensive Care Unit of the Pitie-Salpetriere Hospital in Paris, France
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- years and older
- Admitted in the Cardiac Intensive Care Unit from March 20th 2020
- Patient informed and having expressed his non-opposition to participate in the research
Exclusion Criteria2
- Minor patient
- Patient who expressed opposition to participation in the study
Interventions
OTHERData collection
Diagnostic and prognostic evaluation of cardiac patients hospitalized in CCU during the COVID-19 outbreak; patient's immune status regarding the presence of SARS-CoV-2 specific antibodies
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04344912
Related Trials
Mind Your Heart-II
NCT054311921 location
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations